Injectable versions of some widely used cancer drugs may be excluded from the new Medicare price negotiations until the 2030s, Reuters reported July 28.
Author: Mariah Taylor
Cancer treatment is more than its therapies, and hospitals are utilizing a number of medical practices, social determinants of health programs and technologies to make cancer care more accessible and effective.
Here are nine cancer studies and research you might have missed:
Oncology leaders face many challenges in the field, and three in particular are top of mind: timeliness, treatment options and innovations.
Many agencies are delaying cancer trials and research due to cancer drug shortages, which may have a long-term effect on treatments, CNN reported July 20.
Richard Creech, MD, a pioneering medical oncologist, researcher and longtime leader, died July 1 of cancer at 83, The Philadelphia Inquirer reported July 19.
A breast cancer vaccine has shown promise in a phase 1 trial spearheaded by researchers at University of Washington's Cancer Vaccine Institute and is preparing to move to phase 2, a July 17 Fred Hutchinson Cancer Center news release said.
Michael Postow, MD, chief of melanoma service at Memorial Sloan Kettering Cancer Center in New York City, picked oncology because it was a place where he could make the biggest impact.
Detroit-based Barbara Ann Karmanos Cancer Institute named Arnold D'Ambrosio chief development officer, effective July 10.
Here are the top four cancer hospitals in North Dakota, according to U.S. News & World Report rankings.
